Skip to content

Insider · CIK 0001773314

Allene M. Diaz

director

Files at IONS (IONIS PHARMACEUTICALS INC), MRSN (Mersana Therapeutics, Inc.). First filing Aug 26, 2025, latest Aug 26, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $61k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IONS: IONIS PHARMACEUTICALS INC

IONSOct 9, 2026 · close 45.28

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
17Weak
IONSsell 1310b5-1
IONIS PHARMACEUTICALS INC
$61k
1,427 shares
-7%+67% from low-2% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 22, 2025IONS
IONIS PHARMACEUTICALS INC
SOpen-market sale
Common Stock10b5-1
-1,427$42.53$61k18,368Aug 26, 2025
Jul 15, 2025IONS
IONIS PHARMACEUTICALS INC
MOption exercise
Common Stock
+4,079$0.00$019,795Jul 17, 2025
Jul 15, 2025IONS
IONIS PHARMACEUTICALS INC
MOption exercise
Restricted Stock Unitderivative
-4,079$0.00$05,220Jul 17, 2025
Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
AGrant or award
Non-Qualified Stock Option (right to buy)derivative
+11,518$0.00$011,518Jul 2, 2025
Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
AGrant or award
Restricted Stock Unitderivative
+5,220$0.00$09,299Jul 2, 2025
Jun 12, 2025MRSN
Mersana Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+61,500$0.00$061,500Jun 13, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Allene M. Diaz: insider trades and track record | InsiderTell